ÇAVUŞOĞLU, Y. Et Al. 2014. Levosimendan shows potential renoprotective effect in addition to a better hemodynamic profile over dobutamine in patients presenting with acute heart failure syndromes. Heart Failure Congress 2014 and the 1st World Congress on Acute Heart Failure , 159-160.

ÇAVUŞOĞLU, Y., gencer, e., MUTLU, F., nadir, a., MERT, K. U., morrad, b., ... erarslan, s.(2014). Levosimendan shows potential renoprotective effect in addition to a better hemodynamic profile over dobutamine in patients presenting with acute heart failure syndromes . Heart Failure Congress 2014 and the 1st World Congress on Acute Heart Failure (pp.159-160).

ÇAVUŞOĞLU, YÜKSEL Et Al. "Levosimendan shows potential renoprotective effect in addition to a better hemodynamic profile over dobutamine in patients presenting with acute heart failure syndromes," Heart Failure Congress 2014 and the 1st World Congress on Acute Heart Failure, 2014

ÇAVUŞOĞLU, YÜKSEL Et Al. "Levosimendan shows potential renoprotective effect in addition to a better hemodynamic profile over dobutamine in patients presenting with acute heart failure syndromes." Heart Failure Congress 2014 and the 1st World Congress on Acute Heart Failure , pp.159-160, 2014

ÇAVUŞOĞLU, Y. Et Al. (2014) . "Levosimendan shows potential renoprotective effect in addition to a better hemodynamic profile over dobutamine in patients presenting with acute heart failure syndromes." Heart Failure Congress 2014 and the 1st World Congress on Acute Heart Failure , pp.159-160.

@conferencepaper{conferencepaper, author={YÜKSEL ÇAVUŞOĞLU Et Al. }, title={Levosimendan shows potential renoprotective effect in addition to a better hemodynamic profile over dobutamine in patients presenting with acute heart failure syndromes}, congress name={Heart Failure Congress 2014 and the 1st World Congress on Acute Heart Failure}, city={}, country={}, year={2014}, pages={159-160} }